(Alliance News) - Scancell Holdings PLC said on Wednesday that an investment vehicle of Non-Executive Director Martin Diggle bought 750,000 shares.
Vulpes Life Sciences Fund paid 10.5 pence per share in a single transaction, worth GBP78,750. Diggle's Vuples now holds a 14.5% stake in Scancell, which develops immunotherapies for the treatment of cancer.
Scancell shares were up 6.9% at 11.49 pence in London on Wednesday.
By Zoe Wickens; firstname.lastname@example.org
Copyright 2020 Alliance News Limited. All Rights Reserved.